N Schelhorn1, S Lamm2, R Fricker1.
Abstract
PURPOSE: This randomised prospective study compared pain during application and efficacy of the palmar subcutaneous single injection block (PSSIB) and the traditional dorsal 2 injection block (DTIB).
METHODS: During a 2 year period, a total of 190 patients with an average age of 43 years (18-82) and an isolated finger injury were included in the study. The injection was applied by residents (n=29) of the emergency department. 96 patients received PSSIB (72 men, 24 women) and 94 DTIB (55 men, 39 women) with 3 ml of Mepicavain(®) 1%. Randomisation was performed by even/odd hospital admission number. EXCLUSION CRITERIA: Thumb injury, progressive infection with visible redness at injection point. Application pain was recorded immediately after injection and registered on a VAS (0-10). Efficacy was checked 5 min after application. The patients quoted the efficacy as complete pain-free, almost pain-free and inadequate anesthesia (second injection was necessary). Statistical analysis was performed using the chi-quadrat and the t test; the level of significance was set at p<0.05.
RESULTS: There was no significant difference in terms of analgesic efficacy (p=0,096), while the PSSIB required fewer second injections. Application pain was rated as being significantly (p=0.002) less painful for PSSIB (3.2) than for DTIB (4,0).
CONCLUSIONS: This study shows that PSSIB gives reliable analgesia and the application pain is significant less than during DTIB. © Georg Thieme Verlag KG Stuttgart · New York.
Entities:
Mesh:
Substances:
Year: 2016
PMID: 27580443 DOI: 10.1055/s-0042-113191
Source DB: PubMed Journal: Handchir Mikrochir Plast Chir ISSN: 0722-1819 Impact factor: 1.018